Argentina: Materna extends its sphere of influence in pre- and post-natal care:
This article was originally published in Clinica
Executive Summary
Materna, the Argentine internet-based forum of information on pregnancy and infancy care, has doubled its membership during 2005, to more than 60,000. Materna has emerged as an influential presence in the country's antenatal and postnatal markets, offering a potential opening for medical technology companies. At the end of 2004, it claimed it had attracted more than 25,000 members within 18 months of being established and the backing of "associate brands" from pharmaceutical and domestic goods companies (see Clinica No 1145, p 10). Earlier this year, it said it expected to grow to 120,000 members by the end of 2006.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.